PATIENT ADVOCATE AND SITE SPOTLIGHT Cultural Change in Clinical Trial Development with a Patient and Sites Expert Panel

  • Establishing a panel of patients, researchers and healthcare professionals: How a standing panel of experts provides ongoing insights that help shape research, clinical trial development, participant-facing materials and decision-making.
  • Turning lived experience into action: Real examples of how panel feedback has influenced communication materials.
  • Driving cultural change through partnership: How co-creating and co-delivering training on cultural sensitivity, social determinants of health, and unconscious bias helps clinical trial managers to ensure more inclusive clinical research practices.
  • Awards to drive culture change: How evaluating award submissions and celebrating great patient and site engagement examples helps drive a culture change.

Europe’s Clinical Development Comeback: Compete in Speed, Science and Strategy

  • Understanding the shift: what is driving competitors’ rapid growth in early-phase, oncology, and cell and gene therapy trials across the US, China, and other regions, and why the gap is driven more by execution than by cost or technology
  • Where Europe still leads: scientific excellence, high-quality multi-country data accepted by global regulators, and diverse patient populations that strengthen global filings
  • Turning reform into real speed: what the EU CTR, the planned EU Biotech Act, and Germany’s Medical Research Act can deliver, and what sponsors, sites, and ethics committees must do to accelerate progress
  • From competition to collaboration: designing global development strategies

PRIZE DRAW

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

Sponsored by Dr. Vince Clinical Research

FIRESIDE CHAT Are large CRO operating models equipped to support the agility and priorities of small biotechs?

  • Navigating traditional and niche CRO models as an emerging biotech
  • Understanding the key differences between big pharma and biotech approaches to clinical trial execution and outsourcing strategy
  • Examining how niche and specialist vendors are addressing sponsor pain points with more tailored, flexible solutions
  • Identifying how sponsors and providers can better align expectations, communication models, and operational support for successful partnerships

Moderator: Natasha Mühlemann, SVP Clinical Development, CurieBio